Conversation with The Cancer Letter St. Jude’s Heather Brandt: NCI cancer centers must leverage community trust to boost HPV vaccine uptake in children July 21, 2023Vol.49 No.29By Matthew Bin Han Ong
Conversation with The Cancer Letter NCI’s Douglas Lowy: HPV vaccination is important, but it’s even more important to get screened July 21, 2023Vol.49 No.29By Matthew Bin Han Ong
Guest Editorial The new breast cancer screening guidelines are not enough to save Black womenA breast surgical oncologist and breast radiologist weigh in July 14, 2023Vol.49 No.28By Vivian Jolley Bea and Kemi Babagbemi
Start breast cancer screening at 40, but screen every two years, USPSTF says. Will America listen? May 12, 2023Vol.49 No.19By Matthew Bin Han Ong
Conversation with The Cancer Letter USPSTF’s Wanda Nicholson: Screening saves lives, but screening alone won’t fix disparities in cancer deaths May 12, 2023Vol.49 No.19By Matthew Bin Han Ong
Guest Editorial USPSTF breast cancer screening guidelines are clear, concise; now let’s address gaps in quality May 12, 2023Vol.49 No.19By Otis W. Brawley
Guest Editorial CPRIT leaders: Texas ruling that curbs USPSTF authority threatens progress against cancer April 21, 2023Vol.49 No.16By Michelle M. Le Beau, Ramona Magid and Patty Moore
Conversation with The Cancer LetterJudiciary Bipartisan Policy Center’s Anand Parekh: Rulings on USPSTF, mifepristone are ideological threats to evidence-based care April 14, 2023Vol.49 No.15By Matthew Bin Han Ong
Texas federal judge invalidates ACA preventive care mandate—USPSTF, cancer screening, and PrEP in jeopardy March 31, 2023Vol.49 No.13By Matthew Bin Han Ong
